|
|||||
|
|

Plant-based food and beverage company SunOpta (NASDAQ:STKL) announced better-than-expected revenue in Q3 CY2025, with sales up 16.6% year on year to $205.4 million. The company’s full-year revenue guidance of $872.5 million at the midpoint came in 7.9% above analysts’ estimates. Its non-GAAP profit of $0.05 per share was $0.02 above analysts’ consensus estimates.
Is now the time to buy STKL? Find out in our full research report (it’s free for active Edge members).
SunOpta’s third quarter results showed strong revenue growth, but the market responded negatively as operational challenges weighed on profitability. Management attributed the 17% volume growth to broad-based demand in plant-based beverages, fruit snacks, and foodservice channels, with CEO Brian Kocher noting, “Our categories are roaring. Our customers are voting with their business, and they are voting for us.” However, Kocher also acknowledged that the rapid pace of growth strained the company’s production network, leading to higher maintenance and overtime costs, and delays in margin improvement initiatives.
Looking forward, SunOpta’s guidance is underpinned by expanding production capacity and recovery plans for operational inefficiencies. Management sees continued momentum in plant-based beverages and fruit snacks, expecting incremental benefits as additional lines and wastewater improvements come online. CFO Greg Gaba cautioned that temporary cost pressures will persist into the first half of next year but emphasized, “Once we get the new line in [Midlothian] with the fixed cost leverage, we expect to see some huge margin improvement.” The company is focused on executing these plans to achieve its long-term growth and margin targets by 2027.
Management explained that exceptional demand from both existing and new customers drove robust volume growth, but this also created short-term operational bottlenecks and higher costs that pressured margins.
SunOpta’s outlook is shaped by ongoing investments in production capacity, near-term operational recovery plans, and continued category growth in plant-based beverages and fruit snacks.
Looking ahead, our analysts will be watching (1) the pace and effectiveness of operational recovery measures, particularly at the Midlothian facility; (2) the on-time installation and ramp-up of the new aseptic processing line and wastewater management systems; and (3) continued volume growth in key categories such as plant-based beverages and fruit snacks. Successful execution in these areas will be crucial for SunOpta to deliver on its margin and growth targets.
SunOpta currently trades at $5.05, down from $5.27 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-06 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Nov-05 | |
| Nov-04 | |
| Nov-03 | |
| Oct-29 | |
| Oct-28 | |
| Oct-08 | |
| Oct-03 | |
| Sep-25 | |
| Sep-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite